J-GLOBAL ID:201201047555958064   Update date: Aug. 31, 2020

Kanda Mitsuro

Kanda Mitsuro
MISC (189):
  • Fuminori Sonohara, Feng Gao, Naoki Iwata, Mitsuro Kanda, Masahiko Koike, Naoki Takahashi, Yasuhide Yamada, Yasuhiro Kodera, Xin Wang, Ajay Goel. Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Annals of surgery. 2019. 269. 5. 879-886
  • Chie Tanaka, Michitaka Fujiwara, Mitsuro Kanda, Kenta Murotani, Naoki Iwata, Masamichi Hayashi, Daisuke Kobayashi, Suguru Yamada, Yasuhiro Kodera. Optical trocar access for initial trocar placement in laparoscopic gastrointestinal surgery: A propensity score-matching analysis. Asian journal of endoscopic surgery. 2019. 12. 1. 37-42
  • Bin Sato, Mitsuro Kanda, Chie Tanaka, Daisuke Kobayashi, Naoki Iwata, Norifumi Hattori, Masaya Suenaga, Masamichi Hayashi, Suguru Yamada, Kenta Murotani, Michitaka Fujiwara, Yasuhiro Kodera. Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2-4 Gastric Cancer After Radical Gastrectomy. World journal of surgery. 2018. 42. 10. 3277-3285
  • Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y. Expression of sushi domain containing two reflects the malignant potential of gastric cancer. Cancer medicine. 2018
  • Sawaki K, Kanda M. ASO Author Reflections: Troponin I2-A Specific Biomarker for Detection and Prediction of Peritoneal Metastasis in Gastric Cancer. Annals of surgical oncology. 2018
Lectures and oral presentations  (7):
  • B-cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
  • Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts
  • Overexpression of melanoma-associated antigen D4 as an independent prognostic factor in squamous cell carcinoma of the esophagus.
  • Neoadjuvant chemotherapy with S-1 in patients with borderline resectable pancreatic cancer with involvement of the major vessels.
  • Combination of Preoperative Serum CEA and CA19-9 is a Simple and Prominent Predictor in Pancreatic Cancer.
Education (2):
  • 2007 - 2010 Nagoya University Graduate School, Division of Medical Sciences
  • - 2001 Nagoya University Faculty of Medicine
Work history (3):
  • 2013/04/01 - 現在 Nagoya University
  • 2012/09/01 - 2013/03/31 Nagoya University
  • 2010/09/01 - 2012/08/31 Johns Hopkins University, postdoctoral fellow
Association Membership(s) (3):
Asian-Pacific Hepato-Pancreatro-Biliary Association ,  European Society of Medical Oncology ,  American Association for Cancer Research
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page